Overview
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.
Latest 10-K: FY2026, filed Sep 4, 2026 · Open the 10-K (Inline XBRL) ↗
- Revenue
- $0.00B
- n/mYoY
- TotalRevenue
- Gross profit
- Not reported
- Operating income
- -$0.00B
- n/mYoY
- OperatingIncome
- Net income
- -$0.00B
- n/mYoY
- NetIncome
- Diluted EPS
- -$0.03
- n/mYoY
- EPSDiluted
- Diluted shares
- 41.8M
- n/mYoY
- WeightedAvgSharesDiluted
At a glance
Growth
- Revenue grew faster than the median S&P 500 member in 0 of the last 2 fiscal years.
Per share
- Diluted EPS was -$0.03.
Insiders & holders
- Insiders reported no open-market purchases or sales on Form 4 in the past 12 months.
Written from the filed figures on this page by fixed rules — no AI.
Data as of Oct 23, 2026 · Sources: SEC EDGAR 10-K
Financial statements
Annual figures from the 10-K, most recent fiscal year first.
Income Statement
5 annual periodsChip: YoY change.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $0.00Mn/m | $0.00Mn/m S&P 500 6.4% | $0.00Mn/m S&P 500 4.5% | $0.00M100.0%down S&P 500 4.8% | $0.00037M10.5%down S&P 500 10.3% | n/m |
| Gross Profit Median of 315 / 498 | — | — | — | $0.00M100.0%down S&P 500 5.2% | $0.00037M S&P 500 8.3% | — |
| Operating Income Median of 373 / 498 | negative: -$0.99Mn/m | negative: -$0.15Mn/m S&P 500 7.3% | negative: -$0.10Mn/m S&P 500 7.4% | negative: -$0.16Mn/m S&P 500 4.9% | negative: -$0.18Mn/m S&P 500 7.5% | n/m |
| Net Income | negative: -$1.16Mn/m | negative: -$0.08Mn/m S&P 500 4.8% | negative: -$0.10Mn/m S&P 500 5.7% | negative: -$0.16Mn/m S&P 500 1.9% | negative: -$0.18Mn/m S&P 500 1.3% | n/m |
| EPS (Diluted) | negative: -$0.03‡n/m | $0.00n/m S&P 500 6.2% | negative: -$0.01n/m S&P 500 7.9% | negative: -$0.01n/m S&P 500 1.9% | negative: -$0.01 S&P 500 1.5% | n/m |
‡ Share basis changed between these years (stock split or reverse split).
Balance Sheet
5 annual periodsChip: YoY change.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Total Assets | $0.58Mn/m | $0.00M100.0%down S&P 500 5.6% | $0.000014M133.3%up S&P 500 3.4% | $0.0000060M97.7%down S&P 500 4.1% | $0.00026M547.5%up S&P 500 2.2% | 589.0% |
| Total Liabilities Median of 357 / 498 | $0.97M58.7%down | $2.34M2.3%down S&P 500 6.4% | $2.40M4.3%up S&P 500 1.9% | $2.30M7.3%up S&P 500 2.9% | $2.14M9.2%up S&P 500 2.0% | -18.0% |
| Stockholders' Equity | negative: -$0.38Mn/m | negative: -$2.34Mn/m S&P 500 6.8% | negative: -$2.40Mn/m S&P 500 5.4% | negative: -$2.30Mn/m S&P 500 7.3% | negative: -$2.14Mn/m S&P 500 2.5% | n/m |
| Cash & Equivalents | $0.0010Mn/m | $0.00M100.0%down S&P 500 5.2% | $0.000014M133.3%up S&P 500 1.9% | $0.0000060M97.7%down S&P 500 6.7% | $0.00026M547.5%up S&P 500 -8.6% | 40.3% |
| Total Debt Median of 393 / 498 | $0.09M†55.7%down | $0.20M†38.3%down S&P 500 2.3% | $0.33M† S&P 500 0.1% | — | — | — |
† Sum of short-term and long-term debt; the company files no total-debt line.
Cash Flow Statement
5 annual periodsChip: YoY change.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Operating Cash Flow | negative: -$0.12Mn/m | negative: -$0.04Mn/m S&P 500 6.3% | negative: -$0.03Mn/m S&P 500 4.8% | negative: -$0.04Mn/m S&P 500 9.9% | negative: -$0.06Mn/m S&P 500 -0.7% | n/m |
| Capital Expenditures | $0.32Mn/m | $0.00M S&P 500 5.4% | — | — | — | — |
| Free Cash Flow Median of 378 / 498 | negative: -$0.44Mn/m | negative: -$0.04M S&P 500 7.3% | — | — | — | — |
n/m: not meaningful — the base (the prior year, or the first year for the CAGR) was zero or negative, or a per-share figure’s share basis changed (stock split). “—” means the figure is not available.
S&P 500 median = median of the companies in the index on Dec 31 of each fiscal year, from their own 10-K filings; a change counts only companies whose prior year was positive. Each median uses every member that reports the line item; where fewer than 80% do (banks and insurers file no gross profit), the row names how many. Published where at least 250 companies report it. Updated 2026-10-20. This compares reported figures, not share-price returns. Methodology
Ratios & valuation
FY2026Every ratio read two ways: Wall Street’s popular formula and the value investor’s stricter one. Same question, same unit. Pick a ratio.
Valuation · Earnings yield
What a dollar of market value earned
n/m
Wall Street
on net earnings
FY2025 n/m
negative: −4.8%
Value investor
on free cash flow
FY2025 negative: −2.2%
How it’s calculated
Wall Street · on net earnings
Diluted EPS ÷ fiscal-year-end share price (1 ÷ P/E)
pe_ratio (ratio table)
P/E n/mValue investor · on free cash flow
(Operating cash flow − capital expenditures) ÷ market capitalisation (fiscal-year-end close × weighted-average diluted shares)
free cash flow ÷ market cap
Valuation · Book yield
Net assets behind a dollar of market value
n/m
Wall Street
on book equity
FY2025 n/m
n/m
Value investor
on tangible book
FY2025 n/m
How it’s calculated
Wall Street · on book equity
Book value of equity ÷ market capitalisation (1 ÷ P/B)
pb_ratio (ratio table)
Value investor · on tangible book
Tangible book value (equity less goodwill and intangibles) ÷ market capitalisation
tangible_book_value_per_share ÷ (pb_ratio × book_value_per_share)
Quality · Return on capital
Profit earned on the money in the business
n/m
Wall Street
ROE: net income ÷ equity
FY2025 n/m
n/m
Value investor
ROIC: after-tax operating profit ÷ invested capital
FY2025 — Not reported
How it’s calculated
Wall Street · ROE: net income ÷ equity
Net income ÷ average stockholders' equity (start and end of year), including noncontrolling interests. Buybacks shrink equity and lift it.
return_on_equity (ratio table)
Value investor · ROIC: after-tax operating profit ÷ invested capital
Operating profit after tax ÷ invested capital (total assets − cash − non-interest-bearing current liabilities), so leverage cannot flatter it
roic (ratio table)
Quality · Cash margin
Cash profit kept from each dollar of sales
n/m
Wall Street
EBITDA margin
FY2025 n/m
n/m
Value investor
Free-cash-flow margin
FY2025 n/m
How it’s calculated
Wall Street · EBITDA margin
EBITDA ÷ revenue
ebitda ÷ revenue
Value investor · Free-cash-flow margin
(Operating cash flow − capital expenditures) ÷ revenue: taxes, interest, working capital and capex all paid
free cash flow ÷ revenue
Balance sheet · Liquidity
Short-term assets per dollar of bills due within a year
0.00×
Wall Street
Current ratio
FY2025 — Not reported
0.00×
Value investor
Quick ratio, inventory excluded
FY2025 — Not reported
Gap Same: Both views read the same
How it’s calculated
Wall Street · Current ratio
Current assets ÷ current liabilities
current_ratio (ratio table)
Value investor · Quick ratio, inventory excluded
(Current assets − inventory) ÷ current liabilities
quick_ratio (ratio table)
Balance sheet · Debt cover
How many times one year of earnings repays all debt
negative: −10.95×
Wall Street
EBITDA ÷ total debt
FY2025 negative: −0.76×
negative: −4.97×
Value investor
FCF ÷ total debt
FY2025 negative: −0.21×
Gap +5.98×: Value-investor figure 5.98 higher
How it’s calculated
Wall Street · EBITDA ÷ total debt
EBITDA ÷ total debt (short-term + long-term)
ebitda ÷ total debt
Value investor · FCF ÷ total debt
Free cash flow ÷ total debt: what is actually left to repay it
free cash flow ÷ total debt
Each ratio measures one thing two ways, in the same unit: the popular formula, then a stricter one, so a lower figure is the stricter reading. Gap = value-investor figure minus Wall Street figure, from the figures shown.
Price-based ratios use the fiscal-year-end closing price. Free cash flow = operating cash flow − capital expenditures (we compute it; filings rarely report it). n/m = not meaningful (denominator ≤ 0); “—” = not reported. Each ratio’s formulas are under “How it’s calculated”.
Smart money
Showing the most recent 5 annual periods. Get longer history on the Pro plan, or the full history (1993–present) plus the smart-money dataset and webhooks on Institutional.
Peers, filings & research
Research Reports
No published research on PAXH yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on PAXH and publish the result to your public profile.
Cite this page
Data as of Oct 23, 2026. Canonical address: https://valuein.biz/data/PAXH
Valuein. (2026, October 23). PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. (PAXH) financial statements, earnings power and smart-money summary [Data set]. Source: SEC EDGAR filings. https://valuein.biz/data/PAXH
@misc{valuein_paxh_2026,
author = {{Valuein}},
title = {PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. (PAXH) financial statements, earnings power and smart-money summary},
year = {2026},
howpublished = {\url{https://valuein.biz/data/PAXH}},
note = {Data as of 2026-10-23; source: SEC EDGAR filings}
}10-K filed Sep 4, 2026 · accession 0001350156-26-000010
Agents: every figure Valuein's tools return carries a fact_id that traces to its SEC filing.
point-in-time · survivorship-free · every number traceable to its SEC filing